Fat food for a bad mood. Could we treat and prevent depression in Type 2 diabetes by means of ω-3 polyunsaturated fatty acids? A review of the evidence

Diabetic Medicine

Volumn 22, Issue 11, 2005, Pages 1465-1475

  Pouwer, Frans ^a   Nijpels, G ^a   Beekman, A T ^a   Dekker, J M ^a   Van Dam, R M ^a   Heine, R J ^a   Snoek, F J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Depression; Diabetes; Metabolic syndrome; Omega 3 polyunsaturated fatty acids; Phospholipids

Indexed keywords

ANTIDEPRESSANT AGENT; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID;

ADJUVANT THERAPY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DEPRESSION; DIET SUPPLEMENTATION; DISEASE SEVERITY; FAT INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; MEDLINE; MOOD; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW;

ADULT; DEPRESSIVE DISORDER; DIABETES MELLITUS, TYPE 2; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS;

EID: 27844602285     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2005.01661.x     Document Type: Review

References (73)

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-1431.
2. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020. Global Burden of Disease Study. Lancet 1997; 349: 1498-1504.
3. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001; 24: 1069-1078.
4. Pouwer F, Beekman AT, Nijpels G, Dekker JM, Snoek FJ, Kostense PJ et al. Rates and risks for co-morbid depression in patients with type 2 diabetes mellitus: results from a community-based study. Diabetologia 2003; 46: 892-898.
5. Eaton WW, Armenian H, Gallo J, Pratt L, Ford DE. Depression and risk for onset of type II diabetes. A prospective population-based study. Diabetes Care 1996; 19: 1097-1102.
6. Kawakami N, Takatsuka N, Shimizu H, Ishibashi H. Depressive symptoms and occurrence of type 2 diabetes among Japanese men. Diabetes Care 1999; 22: 1071-1076.
7. Golden SH, Williams JE, Ford DE, Ych HC, Paton Sanford C, Nieto FJ. Depressive symptoms and the risk of type 2 diabetes: The Atherosclerosis Risk in Communities study. Diabetes Care 2004; 27: 429-435.
8. Saydah SH, Brancati FL, Golden SH, Fradkin J, Harris MI. Depressive symptoms and the risk of type 2 diabetes mellitus in a US sample. Diabetes Metab Res Rev 2003; 19: 202-208.
9. Lustman P, Clouse R. Treatment of depression in diabetes. Impact on mood and medical outcome. J Psychosom Res 2002; 53: 917-924.
10. Talbot F, Nouwen A. A review of the relationship between depression and diabetes in adults: is there a link? Diabetes Care 2000; 23: 1556-1562.
11. Musselman DL, Betan E, Larsen H, Phillips LS. Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry 2003; 54: 317-329.
12. Hibbeln JR, Salem N Jr. Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. Am J Clin Nutr 1995; 62: 1-9.
13. Horrobin DF, Bennett CN. Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Possible candidate genes. Prostaglandins Leukot Essent Fatty Acids 1999; 60: 217-234.
14. Rubin RR, Peyrot M. Was Willis right? Thoughts on the interaction of depression and diabetes. Diabetes Metab Res Rev 2002; 18: 173-175.
15. Jacobson AM, Samson JA, Weinger K, Ryan CM. Diabetes, the brain, and behavior: is there a biological mechanism underlying the association between diabetes and depression? Int Rev Neurobiol 2002; 51: 455-479.
16. Simopoulos AP. Evolutionary aspects of omega-3 fatty acids in the food supply. Prostaglandins Leukot Essent Fatty Acids 1999; 60: 421-429.
17. Hibbeln JR. Fish consumption and major depression. Lancet 1998; 351: 1213.
18. Tanskanen A, Hibbeln JR, Hintikka J, Haatainen K, Honkalampi K, Viinamaki H. Fish consumption, depression, and suicidality in a general population. Arch General Psychiatry 2001; 58: 512-513.
19. Tanskanen A, Hibbeln JR, Tuomilehto J, Untela A, Haukkala A, Viinamaki H et al. Fish consumption and depressive symptoms in the General population in Finland. Psychiatric Services 2001; 52: 529-531.
20. Mamalakis G, Tornaritis M, Kafatos A. Depression and adipose essential polyunsaturated fatty acids. Prostaglandins Leukot Essent Fatty Acids 2002; 67: 311-318.
21. Tiemeier H, Van Tuijl RH, Hofman A, Kiliaan AJ, Breteler MMB. Plasma fatty acid composition and depression are associated in the elderly: the Rotterdam Study. Am J Clin Nutr 2003; 78: 40-46.
22. Suzuki S, Akechi T, Kobayashi M, Taniguchi K, Goto K, Sasaki S et al. Daily omega-3 fatty acid intake and depression in Japanese patients with newly diagnosed lung cancer. Br J Cancer 2004; 90: 787-793.
23. Jacka FN, Pasco JA, Kotowicz MA, Nicholson GC, Berk M. Dietary omega-3 fatty acids and depression in a community sample. Nutritional Neuroscience 2004; 7: 101-106.
24. Hakkarainen R, Partonen T, Haukka J, Virtamo J, Albanes D, Lonnqvist J. Is low dietary intake of omega-3 fatty acids associated with depression? Am J Psychiatry 2004; 161: 567-569.
25. Timonen M, Horrobin D, Jokelainen J, Laitinen J, Herva A, Rasanen P. Fish consumption and depression: the Northern Finland 1966 birth cohort study. J Affect Disord 2004; 82: 447-452.
26. Mamalakis G, Kiriakakis M, Tsibinos G, Kafatos A. Depression and adipose polyunsaturated fatty acids in the survivors of the seven countries study population of Crete. Prostaglandins Leukot Essent Fatty Acids 2004; 70: 495-501.
27. Frasure-Smith N, Lesperance F, Julien P. Major depression is associated with lower omega-3 tatty acid levels in patients with recent acute coronary syndromes. Biol Psychiatry 2004; 55: 891-896.
28. Adams PB, Lawson S, Sanigorski A, Sinclair AJ. Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids 1996; 31 (Suppl.): S157-161.
29. Maes M, Smith R, Christophe A, Cosyns P, Desnycler R, Meltzer H. Fatty acid composition in major depression: decreased omega 3 fractions in cholesteryl esters and increased C20:4 omega-6/C20:5 omega-3 ratio in cholesteryl esters and phospholipids. J Affect Disord 1996; 38: 35-46.
30. Edwards R, Peet M, Shay J, Horrobin D. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord 1998; 48: 149-155.
31. Peet M, Murphy B, Shay J, Horrobin D. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry 1998; 43: 315-319.
32. Maes M, Christophe A, Delanghe J, Altamura C, Neels H, Meltzer HY. Lowered omega-3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res 1999; 85: 275-291.
33. Assies J, Lok A, Bockting CL, Weverling GJ, Lieverse R, Visser I et al. Fatty acids and homocysteine levels in patients with recurrent depression: an explorative pilot study. Prostaglandins Leukot Essent Fatty Acids 2004; 70: 349-356.
34. Stoll AL, Severus WH, Freeman MP, Rueter S, Zboyan HA, Diamond E. Omega-3 fatty acids in bipolar disorder: a preliminary double blind, placebo-controlled trial. Arch General Psychiatry 1999; 56: 407-412.
35. Nemets B, Stahl Z, Belmaker RH. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry 2002; 159: 477-479.
36. Peet M, Horrobin DK. A dose-ranging study of the effects of ethyleicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch General Psychiatry 2002; 59: 913-919.
37. Marangell LB, Martinez JM, Zboyan HA, Kertz. B, Florence Sueng Kim H, Puryear LJ. A double-blind placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry 2003; 160: 996-998.
38. Su KP, Hunag SY, Chiu CC, Shen WW. Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. Eur Neuropsychopharmacol 2003; 13: 267-271.
39. Assies J, Lieverse R, Vreken P, Wanders RJ, Dingemans PM, Linszen DH. Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group. Mol Psychiatry 2001; 49: 510-522.
40. Peet M. Eicosapentaenoic acid in the treatment of schizophrenia and depression: rationale and preliminary double-blind clinical trial results. Prostaglandins Leukot Essent Fatty Acids 2003; 69: 477-485.
41. Lund EK, Harvey LJ, Ladha S, Clark DC, Johnson IT. Effects of dietary fish oil supplementation on the phospholipid composition and fluidity of cell membranes from human volunteers. Ann Nutr Metab 1999; 43: 290-300.
42. Block ER, Fdwards D. Effect of plasma membrane fluidity on serotonin transport by endothelial cells. Am J Physiol 1987; 253: C672-678.
43. Hibbeln JR, Linnoila M, Umhau JC, Rawlings R, George DT, Salem N. Fssential fatty acids predict metabolites of serotonin and dopamine in cerebrospinal fluid among healthy control subjects, and early- and late-onset alcoholics. Biol Psychiatry 1998; 44: 235-242.
44. Maes M, Smith RS. Fatty acids, cytokines, and major depression. Biol Psychiatry 1998; 43: 313-314.
45. Hu FB, van Dam RM, Liu S. Diet and risk of Type II diabetes: the role of types of fat and carbohydrate. Diabetologia 2001; 44: 805-817.
46. Feskens FJ, Virtanen SM, Rasanen L, Tuomilehto J, Stengard J, Pekkanen J. Dietary factors determining diabetes and impaired glucose tolerance. A 20-year follow-up of the Finnish and Dutch cohorts of the Seven Countries Study. Diabetes Care 1995; 18: 1104-1112.
47. Feskens EJ, Bowles CH, Kromhout D. Inverse association between fish intake and risk of glucose intolerance in normoglycemic elderly men and women. Diabetes Care 1991; 14: 935-941.
48. Feskens HJ, Kromhout D. Epidemiologic studies on Eskimos and fish intake. Ann N Y Acad Sci 1993; 683: 9-15.
49. Jorgensen ME, Bjeregaard P, Borch-Johnsen K. Diabetes and impaired glucose tolerance among the Inuit population of Greenland. Diabetes Care 2002; 25: 1766-1771.
50. Salmeron J, Hu FB, Manson JE, Stampfer MJ, Colditz, GA, Rimm EB. Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr 2001; 73: 1019-1026.
51. Meyer KA, Kushi LH, Jacobs DR Jr, Folsom AR. Dietary fat and incidence of type 2 diabetes in older Iowa women. Diabetes Care 2001; 24: 1528-1535.
52. Marshall JA, Bessesen DH, Hamman RF. High saturated fat and low starch and fibre are associated with hyperinsulinaemia in a non-diabetic population: the San Luis Valley Diabetes Study. Diabetologia 1997; 40: 430-438.
53. Van Dam RM, Willett WC, Rimm ER, Stampfer MJ, Hu FB. Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care 2002; 25: 417-424.
54. Vessby B, Unsitupa M, Hermansen K, Riccardi G, Rivellese AA, Tapsell LC et al. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study. Diabetologia 2001; 44: 312-319.
55. Toft I, Bonaa KH, Ingebretsen OC, Nordoy A, Jenssen T. Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension. A randomized, controlled trial. Ann Intern Med 1995; 123: 911-918.
56. Friedberg CE, Janssen MJ, Heine RJ, Grobbee DE. Fish oil and glycemic control in diabetes. A meta-analysis. Diabetes Care 1998; 21: 494-500.
57. Montori VM, Farmer A, Wollan PC, Dinneen SF. Fish oil supplementation in type 2 diabetes: a quantitative systematic review. Diabetes Care 2000: 23: 1407-1415.
58. Weber P, Raederstorff D. Triglyceride-lowering effect of omega-3 long chain polyunsaturated fatty acids-a review. Nutr Metab Cardiovasc Dis 2000; 10: 28-37.
59. Appel LJ, Miller ER 3rd, Seidler AJ, Whelton PK. Does supplementation of diet with 'fish oil' reduce blood pressure? A meta-analysis of controlled clinical trials. Arch Intern Med 1993; 153: 1429-1438.
60. Kris-Etherton PM, Harris WS, Appel LJ; American Heart Association Nutrition Committee. Fish consumption, fish oil, omega-3 fatty-acids and cardiovascular disease. Circulation 2002; 106: 2747-2757.
61. Kris-Etherton PM, Harris WS, Appel LJ; AHA Nutrition Committee. American Heart Association. Omega-3 fatty acids and cardiovascular disease. New recommendations from the American Heart Association. Arterioscler Thromb Vasc Biol 2003; 23: 151-152.
62. Rudisch B, Nemeroff CB. Epidemiology of comorbid coronary artery-disease and depression. Biol Psychiatry 2003; 54: 227-240.
63. Rugulies R. Depression as a predictor for coronary heart disease: a review and meta-analysis (1). Am J Prev Med 2002; 23: 51-61.
64. Mulrow CD, Williams JWR, Gerety MB, Ramirez G, Montiel OM, Kerber C. Case-finding instruments for depression in primary care settings. Ann Intern Med 1995; 122: 913-921.
65. Penninx BW, Beekman AT, Honig A, Deeg DJ, Schoevers RA, van Eijk JT et al. Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry 2001; 58: 221-227.
66. Burg MM, Abrams D. Depression in chronic medical illness: the case of coronary heart disease. J Clin Psychol 2001; 57: 1323-1337.
67. Lloyd CE, Kuller LH, Ellis D, Becker DJ, Wing RR, Orchard TJ. Coronary artery disease in IDDM. Gender differences in risk factors but not risk. Arterioscler Thromb Vasc Biol 1996; 16: 720-726.
68. Forrest KY, Becker DJ, Kuller LH, Wolfson SK, Orchard TJ. Are predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same? A prospective study. Atherosclerosis 2000; 148: 159-169.
69. Peyrot M, Rubin RR. Persistence of depressive symptoms in diabetic adults. Diabetes Care 1999; 22: 448-452.
70. Takahata K, Monobe K, Tada M, Weber PC. The benefits and risks of n-3 polyunsaturated fatty acids. Biosci Biotechnol Biochem 1998; 62: 2079-2085.
71. Harris WS, Ginsberg HN, Arunakul N, Shachter NS, Windsor SL, Adams M. Safety and efficacy of Omacor in severe hypertriglyceridemia. J Cardiovasc Risk 1997; 4: 385-391.
72. Katon WJ. Clinical and health services relationships between depression, depressive symptoms, and general medical illness. Biol Psychiat 2003; 54: 216-226.
73. Franz MJ, Bantle JP, Beebe CA, Brunzell JD, Chiasson JL, Garg A. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 2002; 25: 148-198.